From malaria to blood cancer, researchers in the developing world get the tools they need to fight epidemics through TWAS grants. They're also training scientists who can adjust quickly to work on emerging concerns like Zika.
From dental lasers in Brazil to solar energy in Indonesia, TWAS grants are building careers, advancing science and even helping to influence policy and industry. Grantees came to Trieste to share their stories and insights about building science in the developing world.
Ethel Nakimuli-Mpungu's psychiatric research is helping Ugandans with HIV practice resilience in the face of depression. Her work directly helps people live happier lives, and has won her high praise at home and abroad.
The International Mathematical Union and TWAS team up to provide a new opportunity to early-career mathematicians from developing countries.
On issues ranging from Zika virus and energy to climate change and synthetic biology, governments see science advice as essential for good policy. But if scientists take the wrong approach, their advice could be ignored.
Passione, entusiasmo e supporto finanziario ad hoc sono gli ingredienti che accomunano oltre 40 scienziati del Sud del mondo che la TWAS ha sostenuto finanziariamente. Nel corso di un convegno in programma a Trieste (18-22 aprile) racconteranno qual è stato l'impatto del finanziamento sulla loro carriera e sulla vita.
For the first time in its history, TWAS is hosting some of its leading Research Grant awardees to showcase how passion, enthusiasm – and financial support – can achieve valuable results.
In five years at TWAS, Executive Director Romain Murenzi has been a prominent voice for science policy in the developing world. He oversaw significant growth in PhD fellowships, a new science diplomacy initiative and ambitious new communication outreach.
Usando una combinazione di ingegneria genetica e farmacologia, un team di ricercatori guidati dal biologo molecolare indiano Inder Verma sta testando strategie diverse che potrebbero trasformare il glioblastoma in una malattia curabile.
By combining multiple strategies – from genetic engineering to pharmacology – a research team led by molecular biologist Inder Verma is raising hope that deadly glioblastomas could be transformed into a manageable disease.